Latest immunotherapy Stories
MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license
SEATTLE, Mar. 25, 2015 /PRNewswire/ --TapImmune Inc.
PORTLAND, Oregon, March 25, 2015 /PRNewswire/ -- Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types,
NEW YORK, March 25, 2015 /PRNewswire/ -- The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according
BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies
Presentations to highlight a big data approach for deciphering the applications of immune checkpoint inhibitors and the potential array of therapeutics BRANFORD, Conn., March 24, 2015
BONN, Germany, March 24, 2015 /PRNewswire/ -- Brings Series A total to EUR14.25m to advance RNA-based immunotherapeutics for
A Kirkus review highlights Dr.
According to the new report from BCC Research, global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014.
The Allergy Center at Santa Rosa Head and Neck Surgery (SRHN) reminds Sonoma County residents of the imminent allergy season. Santa Rosa, CA (PRWEB) March 21,
- The governor of a province or people.